Sangamo Therapeutics, Inc.
SGMO
$0.14
$0.014.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.13% | -74.77% | 34.68% | -30.78% | -319.23% |
| Total Depreciation and Amortization | -0.79% | 0.05% | -1.40% | -9.88% | 0.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 622.24% | -5.72% | -13.26% | 31.50% | -31.68% |
| Change in Net Operating Assets | -275.70% | 203.53% | -2,919.48% | -100.48% | 504.88% |
| Cash from Operations | 14.37% | -56.94% | 30.56% | -680.33% | -128.50% |
| Capital Expenditure | 78.13% | -166.67% | -- | -- | -32.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 324.14% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 78.13% | -166.67% | -- | -- | 468.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -22.21% | -32.94% | 180.22% | 43.68% | -- |
| Repurchase of Common Stock | -30.71% | 36.43% | 81.14% | -912.27% | -8.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.95% | -32.89% | 251.78% | 16.35% | 3,543.84% |
| Foreign Exchange rate Adjustments | -4.76% | -98.46% | 113.94% | 156.83% | -299.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.83% | -170.77% | 178.65% | -716.05% | -78.96% |